# clm_E5BECE5372F5

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 4,884,200,000 United States dollar  
valid_from: 2010-12-31  
valid_to: 2011-12-31  
published: 2011-02-22  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_965E7901CE0F  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 4,884,200,000 United States dollar", as of 2010-12-31 (until 2011-12-31). Claim clm_E5BECE5372F5, https://asof.is/claim/clm_E5BECE5372F5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000119312511041620/0001193125-11-041620-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-22  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000119312511041620/0001193125-11-041620-index.htm (primary, SEC EDGAR 10-K FY2010, published 2011-02-22)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 4,326,500,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_E5BECE5372F5](/claim/clm_E5BECE5372F5.md) | [clm_21AC62604A75](/claim/clm_21AC62604A75.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.